Muskonec-SP Tablet
Marketer
Azurite Therapeutics Pvt.Ltd.
Salt Composition
Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Overview Muskonec-SP Tablet
Combiflam-RX tablets combine medications to ease pain and inflammation in conditions such as muscular aches, arthritic joint pain, and post-surgical discomfort. This effectively manages symptoms in rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and duration for Combiflam-RX should strictly follow your physician's instructions. Administering it with food or milk minimizes potential stomach irritation. Consistent, timely use maximizes therapeutic benefit. Continue the prescribed regimen until your doctor advises otherwise. Potential side effects include nausea, vomiting, abdominal pain, dyspepsia, heartburn, elevated liver enzymes, vertigo, somnolence, and diarrhea. Regular monitoring of kidney and liver function, along with blood counts, may be necessary during prolonged therapy. Extended use carries risks such as gastrointestinal bleeding and renal complications. Combiflam-RX is contraindicated in pregnancy and lactation.
Uses of Muskonec-SP Tablet
Analgesia
Major Benefits of Muskonec-SP Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Muskonec-SP Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume with food.
Common Side effects of Muskonec-SP Tablet:
- Nausea
- Vomiting
- Stomach pain
- Indigestion
- Heartburn
- Loss of appetite
- Diarrhea
- Dizziness
- Increased liver enzymes
- Drowsiness
How to use Muskonec-SP Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Muskonec-SP Tablets should be administered with food.
How Muskonec-SP Tablet works:
Muskonec-SP tablets contain a three-drug formulation: aceclofenac, paracetamol, and serratiopeptidase. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the analgesic paracetamol (an antipyretic) reduce pain and fever by inhibiting the production of inflammatory mediators in the central nervous system. Serratiopeptidase, a proteolytic enzyme, facilitates healing by degrading proteins associated with inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Muskonec-SP Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Muskonec-SP Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Muskonec-SP Tablet use while breastfeeding is absent. Seek medical advice.
DrivingUNSAFE
Taking Muskonec-SP Tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Muskonec-SP Tablets cautiously, potentially requiring dosage modification under medical supervision. Muskonec-SP Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Muskonec-SP Tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe or active liver disease.
What if you forget to take Muskonec-SP Tablet :
Should you forget a Muskonec-SP Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Muskonec-SP Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medications for Pain Relief |




